Established in 2016, Revamp medical aims to address the critical unmet needs of Acute Heart Failure patients. The company is focused on leveraging Doraya to empower cardiologists in improving patient response to diuretic therapy, leading to swift relief of congestion symptoms, better patient outcomes, and reduced readmission costs. The Revamp team consists of experienced professionals with a successful history in driving multiple med-tech startups.